BIO.B Bio-Rad Laboratories Inc.

Live Feeds
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds

Live Feeds
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds

Publish Go to App

© 2026 quantisnow.com
Democratizing insights since 2022

Services

Live news feeds RSS Feeds Alerts Publish with Us

Company

About Quantisnow Plus Contact Jobs AI superconnector for talent & startupsNEW LLM Arena

Legal

Terms of use Privacy policy Cookie policy

Subscribe to $BIO.B

Bio-Rad Laboratories Inc.

Subscribe to $BIO.B

00

IPO Year:

Exchange: NYSE

Recent Analyst Ratings for Bio-Rad Laboratories Inc.

Date	Price Target	Rating	Analyst

See more ratings

Bio-Rad Laboratories Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP, President, LSG Barry James sold $214,289 worth of Bio-Rad A Common Stock (700 units at $306.18), decreasing direct ownership by 58% to 510 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

11/10/25 4:15:49 PM ET

President & COO Divincenzo Jonathan P. converted options into 1,869 units of Bio-Rad A Common Stock and covered exercise/tax liability with 950 units of Bio-Rad A Common Stock (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

10/28/25 12:29:44 PM ET

EVP, Global Supply Chain Evran Sedat converted options into 1,044 units of Bio-Rad A Common Stock and covered exercise/tax liability with 335 units of Bio-Rad A Common Stock, increasing direct ownership by 47% to 2,233 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

10/21/25 4:42:00 PM ET

EVP, Global Supply Chain Evran Sedat converted options into 864 units of Bio-Rad A Common Stock and covered exercise/tax liability with 277 units of Bio-Rad A Common Stock, increasing direct ownership by 63% to 1,524 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:24:03 PM ET

EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,535 units of Bio-Rad A Common Stock and covered exercise/tax liability with 550 units of Bio-Rad A Common Stock, increasing direct ownership by 115% to 1,844 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:23:38 PM ET

EVP, Global Human Resources Corey Colleen covered exercise/tax liability with 209 units of Bio-Rad A Common Stock and converted options into 576 units of Bio-Rad A Common Stock, increasing direct ownership by 2% to 19,550 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:23:07 PM ET

EVP, President, LSG Barry James converted options into 1,056 units of Bio-Rad A Common Stock and covered exercise/tax liability with 378 units of Bio-Rad A Common Stock, increasing direct ownership by 128% to 1,210 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:22:18 PM ET

Director Allison Schwartz converted options into 92 units of Bio-Rad A Common Stock and covered exercise/tax liability with 33 units of Bio-Rad A Common Stock, increasing direct ownership by 4% to 1,456 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:21:57 PM ET

SEC Form 4 filed by President & COO Divincenzo Jonathan P.

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:21:33 PM ET

EVP, President, CDG Engelhardt Eva Anette covered exercise/tax liability with 413 units of Bio-Rad A Common Stock and converted options into 1,152 units of Bio-Rad A Common Stock, increasing direct ownership by 471% to 896 units (SEC Form 4)

4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

9/9/25 4:21:06 PM ET

Bio-Rad Laboratories Inc. Press Releases

Fastest customizable press release news feed in the world

Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits

SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostic products, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer. The Element AVITI Sequencing Platform's novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuo

2/8/23 8:00:00 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Bio-Rad Laboratories Inc. SEC Filings

SEC Form 144 filed by Bio-Rad Laboratories Inc.

144 - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

11/6/25 4:24:39 PM ET

SEC Form 10-Q filed by Bio-Rad Laboratories Inc.

10-Q - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

10/29/25 4:18:31 PM ET

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

10/29/25 4:16:49 PM ET

Amendment: SEC Form SCHEDULE 13D/A filed by Bio-Rad Laboratories Inc.

SCHEDULE 13D/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

10/28/25 4:30:22 PM ET

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

9/30/25 6:02:36 AM ET

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

8/26/25 9:00:36 AM ET

SEC Form 10-Q filed by Bio-Rad Laboratories Inc.

10-Q - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

7/31/25 4:17:43 PM ET

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

7/31/25 4:15:57 PM ET

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

7/28/25 4:14:54 PM ET

Bio-Rad Laboratories Inc. filed SEC Form 8-K: Other Events

8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

6/30/25 4:30:47 PM ET

Bio-Rad Laboratories Inc. Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Bio-Rad Laboratories Inc.

SC 13G - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

11/14/24 5:25:27 PM ET

Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

11/12/24 1:27:07 PM ET

Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

11/4/24 11:22:04 AM ET

Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

10/10/24 11:38:06 AM ET

SEC Form SC 13G filed by Bio-Rad Laboratories Inc.

SC 13G - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

10/10/24 11:36:31 AM ET

SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc. (Amendment)

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

3/11/24 9:59:07 AM ET

SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc. (Amendment)

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

2/13/24 5:00:45 PM ET

SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc. (Amendment)

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

2/9/23 11:12:40 AM ET

SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc. (Amendment)

SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

2/9/23 8:23:46 AM ET

SEC Form SC 13D/A filed by Bio-Rad Laboratories Inc. (Amendment)

SC 13D/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

4/11/22 4:46:04 PM ET